Scott Isaacs(@scottisaacsmd) 's Twitter Profile Photo

Our article on intrahepatic hypothyroidism in . The role of liver-specific thyromimetics including . International collaboration with M Shafi Kuchay in Haryana, Rajasthan and anoop misra in New Delhi. Madrigal Pharmaceuticals

Our article on intrahepatic hypothyroidism in #MASLD. The role of liver-specific thyromimetics including #resmetirom. International collaboration with @drshafikuchay in Haryana, Rajasthan and @docanoopmisra in New Delhi. #MASH #livertwitter @MadrigalPharma
account_circle
JHEP Reports(@JHEP_Reports) 's Twitter Profile Photo

🟪NEW Article in press❕

Direct oral anticoagulants in liver cirrhosis: rationale and current evidence

🔓 at 👉jhep-reports.eu/article/S2589-…


🟪NEW Article in press❕

Direct oral anticoagulants in liver cirrhosis: rationale and current evidence

🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
#cirrhosis
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

Precision treatment in advanced HCC
Cancer Cell
doi.org/10.1016/j.ccel…
👏Excellent summary on precision medicine in HCC
👉all you need to know on molecular classification, biomarker, iTME & future directions...
ESMO - Eur. Oncology EASL Education ILCA

Precision treatment in advanced HCC
@Cancer_Cell
doi.org/10.1016/j.ccel…
👏Excellent summary on precision medicine in HCC
👉all you need to know on molecular classification, biomarker, iTME & future directions...
@myESMO @EASLedu @ILCAnews #livertwitter
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

Pre-transplant Use of Immune Checkpoint Inhibitors for HCC
American Journal of Transplantation
doi.org/10.1016/j.ajt.…
🔎 RWD🇨🇳, 83 pts
👉27.7% developed allograft rejection, mortality: 6/83
👉≥ 30 days before TX protective
🤔feasible, but relevant risk
ESMO - Eur. Oncology ILCA EASLnews

Pre-transplant Use of Immune Checkpoint Inhibitors for HCC
@amjtransplant 
doi.org/10.1016/j.ajt.…
🔎 RWD🇨🇳, 83 pts
👉27.7% developed allograft rejection, mortality: 6/83 
👉≥ 30 days before TX protective
🤔feasible, but relevant risk
@myESMO @ILCAnews @EASLnews #livertwitter
account_circle
Ramon Bataller(@rabataller) 's Twitter Profile Photo

There are liver clinics that are fighting to get a dedicated dietitian for people with steatotic liver disease.

With the cost of Resmetirom to treat a patient for 2 years (47k/year), we can probably hire such specialist to help multiple patients. We need both.

account_circle
Ramon Bataller(@rabataller) 's Twitter Profile Photo

How frequent are mental disorders in stetatotic liver disease ?

This huge study including 2.1 million people shows:
🔸26% have depression.
🔸37% have anxiety.
🔸51% are stressed.

We should tackle this to promote lifestyle changes.
t.ly/aU4ZA

How frequent are mental disorders in stetatotic liver disease ?

This huge study including 2.1 million people shows:
🔸26% have depression.
🔸37% have anxiety.
🔸51% are stressed.

We should tackle this to promote lifestyle changes.
t.ly/aU4ZA #livertwitter
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine
ESMO Open
doi.org/10.1016/j.esmo…
🔎systematic review & meta-analysis of 6 trials
👉ORR 10%, DCR 50%, mPFS 3mo, mOS 6,5 mo
🤨Hmm, we need to do better...
ESMO - Eur. Oncology ILCA EASLnews

2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine
@ESMO_Open 
doi.org/10.1016/j.esmo…
🔎systematic review & meta-analysis of 6 trials
👉ORR 10%, DCR 50%, mPFS 3mo, mOS 6,5 mo
🤨Hmm, we need to do better...
@myESMO @ILCAnews @EASLnews #livertwitter
account_circle
Juan Turnes(@jturnesv) 's Twitter Profile Photo

El hígado graso (o enfermedad hepática metabólica) afecta a 1 de cada 4 españoles y ya es la causa de cirrosis hepática y cáncer de hígado de crecimiento más rápido. Y sin embargo, es una gran desconocida

Gracias a Quen Anda Aí? TVG por darle visibilidad 👇

account_circle
Ramon Bataller(@rabataller) 's Twitter Profile Photo

Proof-of-concept clinical trial showing that a GLUTEN-free-diet ameliorates MASLD.

Is it due to decreased carbs intake and BMI or to immune effects ?

Any biomarker for personalized medicine ?

roypounder.apt t.ly/BfN1z

Proof-of-concept clinical trial showing that a GLUTEN-free-diet ameliorates MASLD.

Is it due to decreased carbs intake and BMI or to immune effects ?

Any biomarker for personalized medicine ?

#livertwitter @APandT t.ly/BfN1z
account_circle
Journal of Hepatology(@JHepatology) 's Twitter Profile Photo

Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient

here👉journal-of-hepatology.eu/article/S0168-…

Mathias Jachs
Mattias Mandorfer

Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient

#OpenAccess here👉journal-of-hepatology.eu/article/S0168-…

@mathiasjachs
@MattiasMandorf1
#LiverTwitter
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

🌞Great sunny day in Toronto, just starting the Cholangiocarcinoma in PSC Symposium at University Health Network
🤩Looking forward to great talks and discussion on new strategies for prevention and treatment of cancer in PSC
ESMO - Eur. Oncology EASL Education ILCA Cholangiocarcinoma Foundation Gonzalo Sapisochin

🌞Great sunny day in Toronto, just starting the Cholangiocarcinoma in PSC Symposium at @UHN
🤩Looking forward to great talks and discussion on new strategies for prevention and treatment of cancer in PSC
@myESMO @EASLedu @ILCAnews @curecc #livertwitter @sapisochin
account_circle
Juan Turnes(@jturnesv) 's Twitter Profile Photo

👋 Excelente revisión sobre el manejo de los pacientes con en unidades de Cuidados Intensivos

Tarea pendiente en España (al menos) donde el estigma de la cirrosis limita el acceso a las UCIs de nuestros pacientes 🙁

🔓 doi.org/10.1111/apt.18…

👋 Excelente revisión sobre el manejo de los pacientes con #cirrosis en unidades de Cuidados Intensivos

Tarea pendiente en España (al menos) donde el estigma de la cirrosis limita el acceso a las UCIs de nuestros pacientes 🙁

🔓 doi.org/10.1111/apt.18…

#livertwitter
account_circle
TTS(@ttsorg) 's Twitter Profile Photo

🌟We are thrilled to announce that the 2024 TTS Thomas Starzl Innovation Award has been bestowed upon Dr. Robert A. Montgomery, a trailblazer in the field of transplantation. 🏆 👏

Read more 👉tinyurl.com/4raf3c6y

🌟We are thrilled to announce that the 2024 TTS Thomas Starzl Innovation Award has been bestowed upon Dr. Robert A. Montgomery, a trailblazer in the field of   transplantation. 🏆 👏

Read more 👉tinyurl.com/4raf3c6y

#TransplantTwitter #MedTwitter #LiverTwitter #TTS2024
account_circle
Gut Journal(@Gut_BMJ) 's Twitter Profile Photo

Read the paper by Armando Andres Roca Suarez et al on

'TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism' via

bit.ly/3QyBGFr

Barbara Testoni Fabien Zoulim

Read the paper by @andresroca et al on 

'TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism' via

bit.ly/3QyBGFr

@TestoniResearch @FabienZoulim #HBV #LiverTwitter
account_circle
John Damianos, M.D.(@john_damianosMD) 's Twitter Profile Photo

Oral vancomycin is associated with ⬆️ clinical and endoscopic remission for primary sclerosing cholangitis-associated inflammatory bowel disease.



onlinelibrary.wiley.com/doi/10.1111/ap…

account_circle
Gut Journal(@Gut_BMJ) 's Twitter Profile Photo

Read the paper by Armando Andres Roca Suarez et al on

'TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism' via

bit.ly/3QyBGFr

Barbara Testoni Fabien Zoulim

Read the paper by @andresroca et al on 

'TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism' via

bit.ly/3QyBGFr

@TestoniResearch @FabienZoulim #HBV #LiverTwitter
account_circle
MAIDEN(@MAIDEN_MAFLD) 's Twitter Profile Photo

📣When you manage type 2 diabetes with healthy behaviours, you also manage your risk of fatty liver disease, heart disease and kidney disease.
🚨 , Diabetes, heart disease and stroke, and kidney disease are all connected.

📣When you manage type 2 diabetes with healthy behaviours, you also manage your risk of fatty liver disease, heart disease and kidney disease.
🚨 #MAFLD, Diabetes, heart disease and stroke, and kidney disease are all connected.
#Livertwitter #Medtwitter
account_circle
Ramon Bataller(@rabataller) 's Twitter Profile Photo

This week, the liver community has learned two lessons. First, the great appreciation that we have for each other. And second, that life is precious and it must be lived to the fullest, beyond academics.

account_circle